The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and Amyotrophic Lateral Sclerosis -An updated review
Abstract
Misfolded proteins in the central nervous system can induce oxidative damage, which can contribute to neurodegenerative diseases in the mitochondria. Neurodegenerative patients face early mitochondrial dysfunction, impacting energy utilization. Amyloid-ß and tau problems both have an effect on mitochondria, which leads to mitochondrial malfunction and, ultimately, the onset of Alzheimer's disease. Cellular oxygen interaction yields reactive oxygen species within mitochondria, initiating oxidative damage to mitochondrial constituents. Parkinson's disease, linked to oxidative stress, α-synuclein aggregation, and inflammation, results from reduced brain mitochondria activity. Mitochondrial dynamics profoundly influence cellular apoptosis via distinct causative mechanisms. The condition known as Huntington's disease is characterized by an expansion of polyglutamine, primarily impactingthe cerebral cortex and striatum. Research has identified mitochondrial failure as an early pathogenic mechanism contributing to HD's selective neurodegeneration. The mitochondria are organelles that exhibit dynamism by undergoing fragmentation and fusion processes to attain optimal bioenergetic efficiency. They can also be transported along microtubules and regulateintracellular calcium homeostasis through their interaction with the endoplasmic reticulum. Additionally, the mitochondria produce free radicals. The functions of eukaryotic cells, particularly in neurons, have significantly deviated from the traditionally assigned role of cellular energy production. Most of them areimpaired in HD, which may lead to neuronal dysfunction before symptoms manifest. This article summarises the most important changes in mitochondrial dynamics that come from neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's and Amyotrophic Lateral Sclerosis. Finally, we discussed about novel techniques that can potentially treat mitochondrial malfunction and oxidative stress in four most dominating neuro disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2014) · Physiological Reviews · doi:10.1152/physrev.00026.2013 · Cited by 5,383
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674
Mitochondria: In Sickness and in Health
Nunnari, J., & Suomalainen, A. (2012) · Cell · doi:10.1016/j.cell.2012.02.035 · Cited by 3,479
Oxidative stress: a concept in redox biology and medicine
Sies, H. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.002 · Cited by 2,991
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185
OPA1 Controls Apoptotic Cristae Remodeling Independently from Mitochondrial Fusion
Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.025 · Cited by 1,673
Extensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Molecular mechanisms of N-acetylcysteine actions
Zafarullah, M., Li, W. Q., Sylvester, J., & Ahmad, M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180300001 · Cited by 1,343
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,298
Integrative omics for health and disease
Karczewski, K. J., & Snyder, M. P. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2018.4 · Cited by 1,158
Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967
Mitochondrial dysfunction in Parkinson's disease
Bose, A., & Beal, M. F. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13731 · Cited by 841
The i -AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission
Anand, R., Wai, T., Baker, M. J., Kladt, N., Schauss, A. C., Rugarli, E., & Langer, T. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201308006 · Cited by 812
Mitochondria, oxidative stress and neurodegeneration
Federico, A., Cardaioli, E., Da Pozzo, P., Formichi, P., Gallus, G. N., & Radi, E. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.030 · Cited by 787
The Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786
Zhao, K., Zhao, G.-M., Wu, D., Soong, Y., Birk, A. V., Schiller, P. W., & Szeto, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402999200 · Cited by 782
Mitochondrial defect in Huntington's disease caudate nucleus
Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758
Autophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease
Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738
Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity
Ishihara, N., Eura, Y., & Mihara, K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01565 · Cited by 731
Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Dröse, S., Brandt, U., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905529106 · Cited by 655
Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U., & Reddy, P. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr381 · Cited by 646
Protein transmission in neurodegenerative disease
Peng, C., Trojanowski, J. Q., & Lee, V. M.-Y. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0333-7 · Cited by 625
α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Di Maio, R., Barrett, P. J., Hoffman, E. K., Barrett, C. W., Zharikov, A., Borah, A., Hu, X., McCoy, J., Chu, C. T., Burton, E. A., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf3634 · Cited by 619
Applications of machine learning to diagnosis and treatment of neurodegenerative diseases
Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., Neil, D., Saffari, A., Mead, R., Hautbergue, G. M., Holbrook, J. D., & Ferraiuolo, L. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0377-8 · Cited by 595
Loane, D. J., & Faden, A. I. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.09.005 · Cited by 574
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100339 · Cited by 562
Manoharan, S., Guillemin, G. J., Abiramasundari, R. S., Essa, M. M., Akbar, M., & Akbar, M. D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8590578 · Cited by 523
Battin, E. E., & Brumaghim, J. L. (2009) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-009-9054-7 · Cited by 476
Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target
Barber, S. C., Mead, R. J., & Shaw, P. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.008 · Cited by 474
Manczak, M., & Reddy, P. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds072 · Cited by 453
Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model
Kannan, S., Dai, H., Navath, R. S., Balakrishnan, B., Jyoti, A., Janisse, J., Romero, R., & Kannan, R. M. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003162 · Cited by 399
Injection of isolated mitochondria during early reperfusion for cardioprotection
McCully, J. D., Cowan, D. B., Pacak, C. A., Toumpoulis, I. K., Dayalan, H., & Levitsky, S. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00567.2008 · Cited by 375
Abe, K., Itoyama, Y., Sobue, G., Tsuji, S., Aoki, M., Doyu, M., Hamada, C., Kondo, K., Yoneoka, T., Akimoto, M., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.959024 · Cited by 365
Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
Olsson, B., Johansson, M., Gabrielsson, J., & Bolme, P. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf01061422 · Cited by 351
Oxidative Stress Signaling in Alzheimers Disease
Su, B., Wang, X., Nunomura, A., Moreira, P., Lee, H.-G., Perry, G., Smith, M., & Zhu, X. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898451 · Cited by 344
Repairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337
Schöndorf, D. C., Ivanyuk, D., Baden, P., Sanchez-Martinez, A., De Cicco, S., Yu, C., Giunta, I., Schwarz, L. K., Di Napoli, G., Panagiotakopoulou, V., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.009 · Cited by 337
Mignani, S., El Kazzouli, S., Bousmina, M., & Majoral, J.-P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335
Cell-type-specific profiling of brain mitochondria reveals functional and molecular diversity
Fecher, C., Trovò, L., Müller, S. A., Snaidero, N., Wettmarshausen, J., Heink, S., Ortiz, O., Wagner, I., Kühn, R., Hartmann, J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0479-z · Cited by 323
Determinants and Functions of Mitochondrial Behavior
Labbé, K., Murley, A., & Nunnari, J. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155756 · Cited by 322
Hu, C., Huang, Y., & Li, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010144 · Cited by 302
Microglia Activation as a Biomarker for Traumatic Brain Injury
Hernandez-Ontiveros, D. G., Tajiri, N., Acosta, S., Giunta, B., Tan, J., & Borlongan, C. V. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00030 · Cited by 277
Mitochondrial Dysfunction and Chronic Disease: Treatment With Natural Supplements.
Nicolson, G. L. (2014) · PubMed · Cited by 272
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
Moisan, F., Kab, S., Mohamed, F., Canonico, M., Le Guern, M., Quintin, C., Carcaillon, L., Nicolau, J., Duport, N., Singh-Manoux, A., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312283 · Cited by 244
p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain
Mogi, M., Kondo, T., Mizuno, Y., & Nagatsu, T. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.003 · Cited by 242
Jiang, T., Yu, J., Zhu, X., Wang, H., Tan, M., Cao, L., Zhang, Q., Gao, L., Shi, J., Zhang, Y., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12655 · Cited by 238
Bioenergetic approaches for neuroprotection in Parkinson's disease
Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236
Cha, M.-Y., Han, S.-H., Son, S. M., Hong, H.-S., Choi, Y.-J., Byun, J., & Mook-Jung, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034929 · Cited by 231
Translational Metabolomics: Current Challenges and Future Opportunities
Pinu, F. R., Goldansaz, S. A., & Jaine, J. (2019) · Metabolites · doi:10.3390/metabo9060108 · Cited by 219
Connolly, N. M. C., Theurey, P., Adam-Vizi, V., Bazan, N. G., Bernardi, P., Bolaños, J. P., Culmsee, C., Dawson, V. L., Deshmukh, M., Duchen, M. R., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0020-4 · Cited by 204
Wu, L., Zhang, X., & Zhao, L. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.2262-17.2018 · Cited by 185
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma
Kontush, A., Berndt, C., Weber, W., Akopyan, V., Arlt, S., Schippling, S., & Beisiegel, U. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00458-5 · Cited by 180
Kandimalla, R., Manczak, M., Fry, D., Suneetha, Y., Sesaki, H., & Reddy, P. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw312 · Cited by 179
Manczak, M., Kandimalla, R., Fry, D., Sesaki, H., & Reddy, P. H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw330 · Cited by 179
Quantitative profiling brain proteomes revealed mitochondrial dysfunction in Alzheimer’s disease
Adav, S. S., Park, J. E., & Sze, S. K. (2019) · Molecular Brain · doi:10.1186/s13041-019-0430-y · Cited by 174
Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria
Biswas, S., Dodwadkar, N. S., Piroyan, A., & Torchilin, V. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.032 · Cited by 170
Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo
Eckert, A., Schulz, K. L., Rhein, V. F., & Götz, J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8109-5 · Cited by 170
Carvalho, C., Cardoso, S., Correia, S. C., Santos, R. X., Santos, M. S., Baldeiras, I., Oliveira, C. R., & Moreira, P. I. (2012) · Diabetes · doi:10.2337/db11-1186 · Cited by 161
Shaping the role of mitochondria in the pathogenesis of Huntington's disease
Costa, V., & Scorrano, L. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.65 · Cited by 161
Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
Perier, C., Bové, J., & Vila, M. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4074 · Cited by 158
Amyotrophic Lateral Sclerosis: From Current Developments in the Laboratory to Clinical Implications
Cozzolino, M., Ferri, A., & Teresa Carrì, M. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1760 · Cited by 156
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
Kandimalla, R. J. L., & Reddy, P. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.018 · Cited by 156
Wang, B., Kumar, V., Olson, A. J., & Ware, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00384 · Cited by 147
A New Link to Mitochondrial Impairment in Tauopathies
Schulz, K. L., Eckert, A., Rhein, V. F., Mai, S., Haase, W., Reichert, A. S., Jendrach, M., Müller, W. E., & Leuner, K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8308-3 · Cited by 141
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Sonntag, K.-C., Ryu, W.-I., Amirault, K. M., Healy, R. A., Siegel, A. J., McPhie, D. L., Forester, B., & Cohen, B. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14420-x · Cited by 131
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy
Babu, A., Amreddy, N., Muralidharan, R., Pathuri, G., Gali, H., Chen, A., Zhao, Y. D., Munshi, A., & Ramesh, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15012-5 · Cited by 125
High-throughput sequencing in mitochondrial DNA research
Ye, F., Samuels, D. C., Clark, T. A., & Guo, Y. P. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.05.004 · Cited by 115
Keeney, J. T.-R., Ibrahimi, S., & Zhao, L. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150348 · Cited by 102
Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation.
Sharma, R., Kim, S.-Y., Sharma, A., Zhang, Z., Kambhampati, S. P., Kannan, S., & Kannan, R. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00569 · Cited by 100
Self-citationAmyloid Beta: The Alternate Hypothesis
Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697124 · Cited by 96
Mitochondrial DNA analysis in clinical laboratory diagnostics
Wong, L. C., & Boles, R. G. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.11.003 · Cited by 86
Mignani, S. M., Bryszewska, M. J., Zabłocka, M., Klajnert‐Maculewicz, B., Cladera, J., Shcharbin, D., & Majoral, J. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.09.006 · Cited by 81
Mańczak, M., Sesaki, H., Kageyama, Y., & Reddy, P. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.017 · Cited by 80
Bris, C., Goudenège, D., Desquiret‐Dumas, V., Charif, M., Colin, E., Bonneau, D., Amati‐Bonneau, P., Lenaers, G., Reynier, P., & Procaccio, V. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00632 · Cited by 79
Bielski, E. R., Zhong, Q., Brown, M., & da Rocha, S. R. P. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00320 · Cited by 77
Bannwarth, S., Procaccio, V., & Paquis‐Flucklinger, V. (2005) · Human Mutation · doi:10.1002/humu.20177 · Cited by 71
ER–mitochondria contacts: Actin dynamics at the ER control mitochondrial fission via calcium release
Steffen, J., & Koehler, C. M. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201711075 · Cited by 66
Anis, E., Zafeer, M. F., Firdaus, F., Islam, S. N., Khan, A. A., Ali, A., & Hossain, M. S. (2019) · Phytotherapy Research · doi:10.1002/ptr.6523 · Cited by 65
Sharma, R. B., Naresh, K., Chabre, Y. M., Abbassi, L., Shiao, T. C., & Roy, R. (2014) · Chemical Communications · doi:10.1039/c4cc06191h · Cited by 64
Self-citationTechniques and Pitfalls in the Detection of Pathogenic Mitochondrial DNA Mutations
Moraes, C. T., Atencio, D. P., Oca‐Cossio, J., & Díaz, F. (2003) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60474-6 · Cited by 62
-Omics biomarker identification pipeline for translational medicine
Bravo-Merodio, L., Williams, J. A., Gkoutos, G. V., & Acharjee, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1912-5 · Cited by 51
Multivalent niacin nanoconjugates for delivery to cytoplasmic lipid droplets
Sharma, A., Khatchadourian, A., Khanna, K., Sharma, R. B., Kakkar, A. K., & Maysinger, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.10.025 · Cited by 44
Self-citationTherapeutic Potential of Different Natural Products for the Treatment of Alzheimer’s Disease
Chakraborty, B., Mukerjee, N., Maitra, S., Zehravi, M., Mukherjee, D., Ghosh, A., Massoud, E. E. S., & Rahman, M. H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6873874 · Cited by 43
Self-citationSeneca, S., Vancampenhout, K., Coster, R. V., Smet, J., Lissens, W., Vanlander, A. V., Paepe, B. D., Jonckheere, A. I., Stouffs, K., & Meırleır, L. D. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.49 · Cited by 40
Sharma, R. B., Zhang, I., Abbassi, L., Rej, R. N., Maysinger, D., & Roy, R. (2015) · Polymer Chemistry · doi:10.1039/c4py01761g · Cited by 37
Self-citationMukerjee, N., Al-Khafaji, K., Maitra, S., Wadi, J. S., Sachdeva, P., Ghosh, A., Buchade, R. S., Chaudhari, S. Y., Jadhav, S. B., Das, P., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1036552 · Cited by 34
Self-citationThe role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease
Kim, D., & Mook‐Jung, I. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.12.282 · Cited by 32
Sharma, R. B., Zhang, I., Shiao, T. C., Pavan, G. M., Maysinger, D., & Roy, R. (2016) · Nanoscale · doi:10.1039/c5nr06757j · Cited by 31
Self-citationSharma, A., Neibert, K. D., Sharma, R. B., Hourani, R., Maysinger, D., & Kakkar, A. K. (2011) · Macromolecules · doi:10.1021/ma102354k · Cited by 29
Self-citationDesign and synthesis of multifunctional traceable dendrimers for visualizing drug delivery
Sharma, A., Mejía, D., Maysinger, D., & Kakkar, A. K. (2014) · RSC Advances · doi:10.1039/c4ra02713b · Cited by 24
Sharma, A., Mejía, D., Regnaud, A., Uhlig, N., LI, C. ‐., Maysinger, D., & Kakkar, A. K. (2014) · ACS Macro Letters · doi:10.1021/mz5006298 · Cited by 23
Vancampenhout, K., Caljon, B., Spits, C., Stouffs, K., Jonckheere, A. I., Meırleır, L. D., Lissens, W., Vanlander, A. V., Smet, J., Paepe, B. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112950 · Cited by 17
Cited by
Oxidative Stress: Signaling Pathways, Biological Functions, and Disease
Liu, S., Liu, J., Wang, Y., Deng, F., & Deng, Z. (2025) · MedComm · doi:10.1002/mco2.70268 · Cited by 359
Oxidative stress and mitochondrial impairment: Key drivers in neurodegenerative disorders
Wen, P., Sun, Z., Gou, F., Wang, J., Fan, Q., Zhao, D., & Yang, L. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102667 · Cited by 253
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Metadata
- Authors
- Alqahtani, T., Deore, S. L., Kide, A. A., Shende, B. A., Sharma, R., Dadarao Chakole, R., Nemade, L. S., Kishor Kale, N., Borah, S., Shrikant Deokar, S., Behera, A., Dhawal Bhandari, D., Gaikwad, N., Kalam Azad, A., & Ghosh, A.
- Venue
- Mitochondrion
- Publisher
- Elsevier BV
- Published
- 2023-07
- Volume
- 71
- Pages
- 83-92
- ISSN
- 1567-7249 (ISSN-L)
- OpenAlex
- W4378978362
- Cited by
- 274
- References
- 101
- FWCI
- 20.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.